{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:34:23Z","timestamp":1784309663375,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["RA61\/050"],"award-info":[{"award-number":["RA61\/050"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"crossref","award":["RA60\/042"],"award-info":[{"award-number":["RA60\/042"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s12035-020-01882-w","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T07:02:36Z","timestamp":1581318156000},"page":"2333-2345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Increased Levels of Plasma Tumor Necrosis Factor-\u03b1 Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity"],"prefix":"10.1007","volume":"57","author":[{"given":"Michael","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunee","family":"Sirivichayakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andressa Keiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Michelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"de Oliveira Seme\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Victor","family":"de Lima Pedr\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania G.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decio S.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Geffard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-8675","authenticated-orcid":false,"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buranee","family":"Kanchanatawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"issue":"2","key":"1882_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","volume":"45","author":"RS Smith","year":"1995","unstructured":"Smith RS, Maes M (1995) The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med Hypotheses 45(2):135\u2013141","journal-title":"Med Hypotheses"},{"key":"1882_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.pnpbp.2012.06.014","volume":"42","author":"G Anderson","year":"2013","unstructured":"Anderson G, Maes M (2013) Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog Neuro-Psychopharmacol Biol Psychiatry 42:5\u201319","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1882_CR3","doi-asserted-by":"publisher","unstructured":"Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M (2019) The role of aberrations in the immune-inflammatory reflex system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia. Mol Neurobiol:1\u201320. https:\/\/doi.org\/10.1007\/s12035-019-01737-z","DOI":"10.1007\/s12035-019-01737-z"},{"issue":"6","key":"1882_CR4","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1007\/s12035-017-0751-8","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Hemrungrojn S, Thika S, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G et al (2018) Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia. Mol Neurobiol 55(6):5184\u20135201","journal-title":"Mol Neurobiol"},{"key":"1882_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neubiorev.2016.03.017","volume":"65","author":"J Davis","year":"2016","unstructured":"Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J et al (2016) A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis. Neurosci Biobehav Rev 65:185\u2013194","journal-title":"Neurosci Biobehav Rev"},{"key":"1882_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/0004867414533012","volume":"48","author":"J Davis","year":"2014","unstructured":"Davis J, Moylan S, Harvey BH, Maes M, Berk M (2014) Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries. Aust NZJ Psychiatry 48:512\u2013529","journal-title":"Aust NZJ Psychiatry"},{"issue":"1","key":"1882_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12640-018-9937-8","volume":"35","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019) Eotaxin, an endogenous cognitive deteriorating chemokine (ECDC), is a major contributor to cognitive decline in normal people and to executive, memory, and sustained attention deficits, formal thought disorders, and psychopathology in schizophrenia patients. Neurotox Res 35(1):122\u2013138","journal-title":"Neurotox Res"},{"issue":"2","key":"1882_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/1871527317666181119115532","volume":"18","author":"S Sirivichayakul","year":"2019","unstructured":"Sirivichayakul S, Kanchanatawan B, Thika S, Carvalho AF, Maes M (2019) A new schizophrenia model: immune activation is associated with induction of different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions. CNS Neurol Disord Drug Targets 18(2):124\u2013140","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"1882_CR9","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s12640-018-9987-y","volume":"35","author":"M Maes","year":"2019","unstructured":"Maes M, Kanchanatawan B, Sirivichayakul S, Carvalho AF (2019) In schizophrenia, increased plasma IgM\/IgA responses to gut commensal bacteria are associated with negative symptoms, neurocognitive impairments, and the deficit phenotype. Neurotox Res 35(3):684\u2013698","journal-title":"Neurotox Res"},{"key":"1882_CR10","doi-asserted-by":"publisher","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Carvalho AF (2019) In schizophrenia, psychomotor retardation, with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde. Preprints. https:\/\/doi.org\/10.20944\/preprints201901.0108.v1","DOI":"10.20944\/preprints201901.0108.v1"},{"key":"1882_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1741-7015-10-66","volume":"10","author":"M Maes","year":"2012","unstructured":"Maes M, Berk M, Goehler L, Song C, Anderson G, Ga\u0142ecki P, Leonard B (2012) Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 10:66. https:\/\/doi.org\/10.1186\/1741-7015-10-66","journal-title":"BMC Med"},{"issue":"12","key":"1882_CR12","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1007\/s12035-018-1016-x","volume":"55","author":"M Maes","year":"2018","unstructured":"Maes M, Carvalho AF (2018) The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol 55(12):8885\u20138903","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1882_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.euroneuro.2018.12.008","volume":"29","author":"MN Noto","year":"2019","unstructured":"Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA Jr, Cordeiro Q, Belangero SI et al (2019) Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first-episode psychosis. Eur Neuropsychopharmacol 29(3):416\u2013431","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"1882_CR14","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1007\/s12035-018-1437-6","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes M, Kanchanatawan B, Sirivichayakul S, Carvalho AF (2019) In schizophrenia, deficits in natural IgM Isotype antibodies including those directed to malondialdehyde and azelaic acid strongly predict negative symptoms, neurocognitive impairments, and the deficit syndrome. Mol Neurobiol 56(7):5122\u20135135","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1882_CR15","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1007\/s12035-017-0465-y","volume":"55","author":"B Kanchanatawan","year":"2018","unstructured":"Kanchanatawan B, Sirivichayakul S, Ruxrungtham K, Carvalho AF, Geffard M, Anderson G, Maes M (2018) Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation. Mol Neurobiol 55(3):2214\u20132226","journal-title":"Mol Neurobiol"},{"key":"1882_CR16","doi-asserted-by":"publisher","unstructured":"Matsumoto AK, Maes M, Maes A, Michelin AP, de Oliveira SL, de Lima Pedr\u00e3o JV, Moreira E, Kanchanatawan B et al (2019) In Schizophrenia, PON1 Q192R genotypes and\/or lowered paraoxonase 1 (PON1) enzymatic activity are significantly associated with the deficit syndrome, negative symptoms, formal thought disorders, psychomotor retardation, excitation and increased IgA levels to gram-negative microbiota. Preprints:2019090095. https:\/\/doi.org\/10.20944\/preprints201909.0095.v1","DOI":"10.20944\/preprints201909.0095.v1"},{"key":"1882_CR17","doi-asserted-by":"publisher","first-page":"104408","DOI":"10.1016\/j.phrs.2019.104408","volume":"148","author":"G Morris","year":"2019","unstructured":"Morris G, Puri BK, Olive L, Carvalho AF, Berk M, Maes M (2019) Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: association with inflammation, oxidative and nitrosative stress and autoimmune responses. Pharmacol Res 148:104408","journal-title":"Pharmacol Res"},{"key":"1882_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/978-1-4614-3461-0_1","volume":"750","author":"CJ Binder","year":"2012","unstructured":"Binder CJ (2012) Naturally occurring IgM antibodies to oxidation-specific epitopes. Adv Exp Med Biol 750:2\u201313","journal-title":"Adv Exp Med Biol"},{"key":"1882_CR19","first-page":"2465","volume":"2012","author":"D Weismann","year":"1818","unstructured":"Weismann D, Binder CJ (1818) The innate immune response to products of phospholipid peroxidation. Biochim Biophys Acta 2012:2465\u20132475","journal-title":"Biochim Biophys Acta"},{"key":"1882_CR20","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3892\/or.2015.4095","volume":"34","author":"M D\u00edaz-Zaragoza","year":"2015","unstructured":"D\u00edaz-Zaragoza M, Hern\u00e1ndez-\u00c1vila R, Viedma-Rodr\u00edguez R, Arenas-Aranda D, Ostoa-Saloma P (2015) Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (review). Oncol Rep 34:1106\u20131114","journal-title":"Oncol Rep"},{"key":"1882_CR21","first-page":"5(12)","volume":"20","author":"D Thiagarajan","year":"2016","unstructured":"Thiagarajan D, Frosteg\u00e5rd AG, Singh S, Rahman M, Liu A, Vikstr\u00f6m M, Leander K, Gigante B et al (2016) Human IgM antibodies to malondialdehyde conjugated with albumin are negatively associated with cardiovascular disease among 60-year-olds. J Am Heart Assoc 20:5(12)","journal-title":"J Am Heart Assoc"},{"key":"1882_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrrheum.2016.108","volume":"12","author":"M McMahon","year":"2016","unstructured":"McMahon M, Skaggs B (2016) Autoimmunity: do IgM antibodies protect against atherosclerosis in SLE? Nat Rev Rheumatol 12:442\u2013444","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"1882_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.2174\/1570159X17666181227164947","volume":"17","author":"EG Moreira","year":"2019","unstructured":"Moreira EG, Boll KM, Correia DG, Soares JF, Rigobello C, Maes M (2019) Why should psychiatrists and neuroscientists worry about paraoxonase 1? Curr Neuropharmacol 17(11):1004\u20131020","journal-title":"Curr Neuropharmacol"},{"issue":"1\u20133","key":"1882_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.schres.2015.06.009","volume":"166","author":"FF Brinholi","year":"2015","unstructured":"Brinholi FF, Noto C, Maes M, Bonif\u00e1cio KL, Brietzke E, Ota VK, Gadelha A, Cordeiro Q et al (2015) Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug na\u00efve first-episode psychosis. Schizophr Res 166(1\u20133):225\u2013230","journal-title":"Schizophr Res"},{"key":"1882_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","volume":"30","author":"B Kirkpatrick","year":"1989","unstructured":"Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Res 30:119\u2013123","journal-title":"Psychiatry Res"},{"issue":"3","key":"1882_CR26","first-page":"125","volume":"13","author":"P Kittirathanapaiboon","year":"2005","unstructured":"Kittirathanapaiboon P, Khamwongpin M (2005) The validity of the mini international neuropsychiatric interview (M.I.N.I.) Thai version. J Mental Health Thailand 13(3):125\u2013135","journal-title":"J Mental Health Thailand"},{"key":"1882_CR27","doi-asserted-by":"crossref","unstructured":"Andreasen NC (1989) The scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Brit J Psychiatry (Suppl 7):49\u201358","DOI":"10.1192\/S0007125000291496"},{"key":"1882_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"1882_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799\u2013812","journal-title":"Psychol Rep"},{"key":"1882_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1882_CR31","doi-asserted-by":"publisher","unstructured":"Al-Hakeim HK, Al-Mulla AF, Maes M (2019) The neuro-immune fingerprint of major neuro-cognitive psychosis or deficit schizophrenia: a supervised machine learning study. Preprint. Neurotox Res. https:\/\/doi.org\/10.20944\/preprints201905.0285.v1 in press","DOI":"10.20944\/preprints201905.0285.v1"},{"key":"1882_CR32","unstructured":"CERAD. CERAD \u2013 an overview: the consortium to establish a registry for Alzheimer\u2019s disease. 1986. https:\/\/sites.duke.edu\/centerforaging\/cerad\/. As accessed 11-11-2019"},{"key":"1882_CR33","unstructured":"CANTAB. The most sensitive and validated cognitive research software available. www.cambridgecognition.com\/cantab. As accessed 11-11-2019"},{"issue":"1","key":"1882_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0165-5728(96)00010-0","volume":"65","author":"A Boullerne","year":"1996","unstructured":"Boullerne A, Petry KG, Geffard M (1996) Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis. J Neuroimmunol 65(1):75\u201381","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1882_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-2249.1995.tb08344.x","volume":"101","author":"A Amara","year":"1995","unstructured":"Amara A, Constans J, Chaugier C, Sebban A, Dubourg L, Peuchant E, Pellegrin JL, Leng B et al (1995) Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides. Clin Exp Immunol 101(2):233\u2013238","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1882_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/CIRCGENETICS.108.811638","volume":"1","author":"RJ Richter","year":"2008","unstructured":"Richter RJ, Jarvik GP, Furlong CE (2008) Determination of paraoxonase 1 status without the use of toxic organophosphate substrates. Circ Cardiovasc Genet 1(2):147\u2013152","journal-title":"Circ Cardiovasc Genet"},{"key":"1882_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statistics Society Series b (Methodological) 57:289\u2013300","journal-title":"J Royal Statistics Society Series b (Methodological)"},{"key":"1882_CR38","first-page":"n. 2","volume":"13","author":"CM Ringle","year":"2014","unstructured":"Ringle CM, da Silva D, Bido D (2014) Structural equation modeling with the SmartPLS. Braz J Marketing 13:n. 2","journal-title":"Braz J Marketing"},{"key":"1882_CR39","doi-asserted-by":"publisher","unstructured":"Al-Hakeim HK, Almulla AF, Al-Dujaili AH, Maes M (2019) Construction of a neuro-immune-cognitive pathway-phenotype underpinning the phenome of deficit schizophrenia. Preprints:2019100239. https:\/\/doi.org\/10.20944\/preprints201910.0239.v1","DOI":"10.20944\/preprints201910.0239.v1"},{"issue":"6","key":"1882_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000111367","volume":"15","author":"HA Gelbard","year":"1993","unstructured":"Gelbard HA, Dzenko KA, DiLoreto D, del Cerro C, del Cerro M, Epstein LG (1993) Neurotoxic effects of tumor necrosis factor-alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: Implications for AIDS neuropathogenesis. Dev Neurosci 15(6):417\u2013422","journal-title":"Dev Neurosci"},{"issue":"30","key":"1882_CR41","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.1074\/jbc.M600504200","volume":"281","author":"H Takeuchi","year":"2006","unstructured":"Takeuchi H, Jin S, Wang J, Zhang G, Kawanokuchi J, Kuno R, Sonobe Y, Mizuno T et al (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281(30):21362\u201321368","journal-title":"J Biol Chem"},{"key":"1882_CR42","doi-asserted-by":"publisher","first-page":"861231","DOI":"10.1155\/2014\/861231","volume":"2014","author":"G Olmos","year":"2014","unstructured":"Olmos G, Llad\u00f3 J (2014) Tumor necrosis factor-alpha: a link between neuroinflammation and excitotoxicity. Mediat Inflamm 2014:861231","journal-title":"Mediat Inflamm"},{"issue":"5","key":"1882_CR43","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1517\/14728222.2014.888417","volume":"18","author":"M Maes","year":"2014","unstructured":"Maes M, Anderson G, Kubera M, Berk M (2014) Targeting classical IL-6 signaling or IL-6 trans-signaling in depression? Expert Opin Ther Targets 18(5):495\u2013512","journal-title":"Expert Opin Ther Targets"},{"issue":"6 Pt A","key":"1882_CR44","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","volume":"1863","author":"M Rothaug","year":"2016","unstructured":"Rothaug M, Becker-Pauly C, Rose-John S (2016) The role of interleukin-6 signaling in nervous tissue. Biochim Biophys Acta 1863(6 Pt A):1218\u20131227","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"1882_CR45","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jpsychires.2012.08.016","volume":"46","author":"M Borovcanin","year":"2012","unstructured":"Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Bankovic D, Arsenijevic N, Lukic ML (2012) Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. J Psychiatr Res 46(11):1421\u20131426","journal-title":"J Psychiatr Res"},{"key":"1882_CR46","first-page":"6(2)","volume":"13","author":"S Mori","year":"2016","unstructured":"Mori S, Maher P, Conti B (2016) Neuroimmunology of the interleukins 13 and 4. Brain Sci 13:6(2)","journal-title":"Brain Sci"},{"issue":"9","key":"1882_CR47","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.4049\/jimmunol.1202246","volume":"189","author":"SP Gadani","year":"2012","unstructured":"Gadani SP, Cronk JC, Norris GT, Kipnis J (2012) IL-4 in the brain: a cytokine to remember. J Immunol 189(9):4213\u20134219","journal-title":"J Immunol"},{"key":"1882_CR48","doi-asserted-by":"publisher","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019;in press) Breakdown of the paracellular tight and adherens junctions in the gut and blood-brain barrier and damage to the vascular barrier in patients with deficit schizophrenia. Neurotox Res. https:\/\/doi.org\/10.1007\/s12640-019-00054-6","DOI":"10.1007\/s12640-019-00054-6"},{"issue":"3","key":"1882_CR49","first-page":"401","volume":"41","author":"G Orellana","year":"2013","unstructured":"Orellana G, Alvarado L, Mu\u00f1oz-Neira C, \u00c1vila R, M\u00e9ndez MF, Slachevsky A (2013) Psychosis-related matricide associated with a lesion of the ventromedial prefrontal cortex. J Am Acad Psychiatry Law 41(3):401\u2013406","journal-title":"J Am Acad Psychiatry Law"},{"key":"1882_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2013.00035","volume":"4","author":"G Orellana","year":"2013","unstructured":"Orellana G, Slachevsky A (2013) Executive functioning in schizophrenia. Front Psychiatry 4:1\u201315","journal-title":"Front Psychiatry"}],"updated-by":[{"DOI":"10.1007\/s12035-021-02692-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01882-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-01882-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-01882-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T09:22:57Z","timestamp":1644225777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-01882-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1882"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-01882-w","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12035-021-02692-4","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"30 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12035-021-02692-4","URL":"https:\/\/doi.org\/10.1007\/s12035-021-02692-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants, as well as the guardians of patients (parents or other close family members), provided written informed consent to take part in the study. Approval for the study was obtained from the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (No 298\/57), which is in compliance with the International Guideline for Human Research protection as required by the Declaration of Helsinki, The Belmont Report, CIOMS Guideline and International Conference on Harmonization on Good Clinical Practice (ICH-GCP).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}